/ http://www.slideshare.net/images/logo.gif / ºÝºÝߣShare feed for ºÝºÝߣshows by User: AlexanderLifke https://cdn.slidesharecdn.com/profile-photo-AlexanderLifke-48x48.jpg?cb=1567518991 • More than 15 years experience in tumor immunology,cell biology, molecular biology and virology • Research experience in academia and pharmaceutical industry • In depth knowledge for the preclinical evaluation of novel small- and large molecule drug candidates, particularly antibodies as anti-tumor agents, • Recent focus is the identification, characterization and validation of novel targets for ant-tumor therapies • Evaluation of cancer immune therapeutic approaches such as: - redirection of pathogen specific T-cells against cancer (initiation and development of the concept and design of proof of concept experiments) - in vivo efficacy of T-cell-activating-bispecific (TCB) mol